Status:
WITHDRAWN
Use of Gadolinium in CT Pulmonary Angiography
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
The study will investigate patients with clinical suspicion for pulmonary embolism (PE) who have a contraindication to iodine based contrast. These patients normally get investigated with studies such...
Detailed Description
Contrast enhancement with Gadolinium will be evaluated to assess its efficacy for diagnosis and exclusion of pulmonary embolism in a patient who previously would not have been investigated with CTPA d...
Eligibility Criteria
Inclusion
- Patients suspected of having a Pulmonary embolus
- Allergy to Iodine based intravenous contrast
Exclusion
- Renal impairment
- Less than 20 years of age
- Non-English speaking
- Pregnancy
- Allergy to Gadolinium
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02234375
Start Date
July 1 2017
End Date
December 1 2019
Last Update
February 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114